TY - JOUR
T1 - Incidence and predictors of COPD mortality in Uganda
T2 - A 2-year prospective cohort study
AU - Alupo, Patricia
AU - Wosu, Adaeze C.
AU - Mahofa, Abdallah
AU - Mugenyi, Levicatus
AU - Semakula, Daniel
AU - Katagira, Winceslaus
AU - Kirenga, Bruce
N1 - Publisher Copyright:
© 2021 Alupo et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
PY - 2021/2
Y1 - 2021/2
N2 - Background Data is lacking on outcomes among COPD patients in sub-Saharan Africa. The objective of the study was to assess the incidence and predictors of mortality among COPD patients enrolled in the Uganda Registry for Asthma and COPD. Research question What is the Incidence and predictors of mortality among COPD patients in Uganda? Study design and methods Individuals with a diagnosis of COPD at six hospitals in Uganda were enrolled into the registry, and followed every six months. Mortality was ascertained through post-mortem reports and verbal autopsies. Mortality rates (MR), mortality rate ratios (MRR), and hazard ratios (HR) were computed to assess associations between socio-demographic, behavioural, and clinical characteristics at enrolment into the registry and mortality up to two years after. Results We enrolled 296 COPD patients. Median age was 60 years, and 513% were male. The overall mortality rate was 9590 deaths/1000 person-years. COPD severity by post-bronchodilator FEV1 was the strongest risk factor for mortality. Compared to stage 1, adjusted hazard ratios were as follows for stage 4: 986 (95%CI: 170–5714, p = 0011), stage 3: 616 (95%CI: 125–3032, p = 0025), and stage 2: 176 (95%CI: 033–948, p = 051). Underweight patients had a higher incidence of mortality compared to normal weight patients (MRR: 347 (95%CI: 145–831, p = 00026). Conclusion Among COPD patients in Uganda, two-year mortality is high, and disease severity at baseline was the strongest risk factor for mortality. Our findings suggest the need for early, accurate, diagnosis and management of COPD, to potentially improve survival.
AB - Background Data is lacking on outcomes among COPD patients in sub-Saharan Africa. The objective of the study was to assess the incidence and predictors of mortality among COPD patients enrolled in the Uganda Registry for Asthma and COPD. Research question What is the Incidence and predictors of mortality among COPD patients in Uganda? Study design and methods Individuals with a diagnosis of COPD at six hospitals in Uganda were enrolled into the registry, and followed every six months. Mortality was ascertained through post-mortem reports and verbal autopsies. Mortality rates (MR), mortality rate ratios (MRR), and hazard ratios (HR) were computed to assess associations between socio-demographic, behavioural, and clinical characteristics at enrolment into the registry and mortality up to two years after. Results We enrolled 296 COPD patients. Median age was 60 years, and 513% were male. The overall mortality rate was 9590 deaths/1000 person-years. COPD severity by post-bronchodilator FEV1 was the strongest risk factor for mortality. Compared to stage 1, adjusted hazard ratios were as follows for stage 4: 986 (95%CI: 170–5714, p = 0011), stage 3: 616 (95%CI: 125–3032, p = 0025), and stage 2: 176 (95%CI: 033–948, p = 051). Underweight patients had a higher incidence of mortality compared to normal weight patients (MRR: 347 (95%CI: 145–831, p = 00026). Conclusion Among COPD patients in Uganda, two-year mortality is high, and disease severity at baseline was the strongest risk factor for mortality. Our findings suggest the need for early, accurate, diagnosis and management of COPD, to potentially improve survival.
UR - http://www.scopus.com/inward/record.url?scp=85101347519&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85101347519&partnerID=8YFLogxK
U2 - 10.1371/journal.pone.0246850
DO - 10.1371/journal.pone.0246850
M3 - Review article
C2 - 33571315
AN - SCOPUS:85101347519
SN - 1932-6203
VL - 16
JO - PloS one
JF - PloS one
IS - 2 February
M1 - e0246850
ER -